(CPIX, GCOM, EXEL) CRWENewswire Stocks to Watch
On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $93.3 million, compared to $40.8 million for the comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX - reported that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote (acetylcysteine) Injection, which is used to treat acetaminophen poisoning.

*********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

ユーザー：karmastock
再生時間：00:01:13
投稿日時：12/02/09 11:40
カテゴリ：ビジネス全般 
タグ： acetylcysteine  acetaminophen  Cumberland  Globecomm  Exelixis  GCOM  EXEL  CPIX  Nasdaq:CPIX  Nasdaq:EXEL  Nasdaq:GCOM 

[ 前ページへ戻る ]